Snowball logo
logo
547A

Ambu A/S

€10.60+€0.09  (0.86%)
Estimate
P/E
40.8
EPS
0.26
Beta
1.388
Growth
Revenue, YoY
5.41%
Net income, YoY
-17.12%
FCF, YoY
19.48%
Dividends
Dividend yield
0.07%
Annual payout
DKK 0.05
Next ex. div date
December 4, 26
Payout
21.2%
Div.growth, 5y
7.17%
Dividend growth streak
1 year
Div.rating
About the company
Ticker
547A
ISIN
DK0060946788
Country
Denmark
Sector (GICS)
Healthcare
Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products; and cardiology products comprising ECG electrodes. It also provides airway management and anaesthesia products, which include double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers emergency care and training products, such as extrication collars and ALS and BLS training manikins, as well as mobile workstations, IOMs, and patient monitoring and diagnostics devices. Further, the company manufactures video capture solutions for OEMs in medical and defense imaging applications. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.

Frequently asked questions

What sector does Ambu A/S (547A) operate in?

Ambu A/S belongs to the Healthcare sector and operates in the Medical Devices industry.

What is Ambu A/S (547A) current stock price?

As of the latest data, Ambu A/S stock price is €10.60, with a previous close of €10.51. Ambu A/S gained €0.09 in the last trading session, representing a 0.86% increase.

What is Ambu A/S (547A) current market capitalization?

Ambu A/S market cap is approximately 2.40 billion.

What is Ambu A/S (547A) Earnings Per Share (EPS)?

The trailing EPS is €0.26.

What is Ambu A/S (547A) Price-to-Earnings (P/E) ratio?

Ambu A/S current P/E ratio is 40.77.

What is Ambu A/S (547A) EBITDA?

Ambu A/S EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 43.75 million.

Does Ambu A/S (547A) pay dividends?

Yes. Ambu A/S pays annual dividends with an annualized yield of 0.07% and an estimated annual payout of €0.05 per share.

When is the next ex-dividend date for Ambu A/S (547A)?

The next ex-dividend date is scheduled for December 04, 2026.

When is Ambu A/S (547A) next earnings report?

Ambu A/S is expected to release its next earnings report on September 30, 2026.

What is Ambu A/S (547A) beta (volatility) score?

Ambu A/S has a beta of 1.388, suggesting it is more volatile than the market.